Results 311 to 320 of about 152,178 (350)

Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies

Breast Cancer Research and Treatment, 2021
N. Dempsey, A. Rosenthal, Nitika Dabas, Yana Kropotova, M. Lippman, N. Bishopric   +5 more
semanticscholar   +1 more source

Poziotinib/trastuzumab-deruxtecan/trastuzumab-emtansine

Reactions Weekly, 2022
openaire   +1 more source

Trastuzumab Deruxtecan: First Approval

Drugs, 2020
S. Keam
semanticscholar   +1 more source

Trastuzumab--mechanism of action and use in clinical practice.

New England Journal of Medicine, 2007
C. Hudis
semanticscholar   +1 more source

Pertuzumab/trastuzumab/trastuzumab-emtansine

Reactions Weekly, 2020
openaire   +1 more source

Trastuzumab

Reactions Weekly, 2022
openaire   +1 more source

Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab

Signal Transduction and Targeted Therapy, 2021
Weimiao Li, An-Gang Yang, Lin-Tao Jia
exaly  

Trastuzumab

Reactions Weekly, 2023
openaire   +1 more source

Trastuzumab

Reactions Weekly, 2020
  +4 more sources

Trastuzumab

Reactions Weekly, 2021
openaire   +2 more sources